Madaus Martin D 4

What Happened
Martin D. Madaus, a director of Hologic, Inc. (HOLX), received an award of 3,190 restricted stock units (RSUs) reported on Feb 26, 2026. The filing shows these are RSU grants (award/acquisition code A); no purchase price or immediate share transfer is reported. The units will convert to common stock upon vesting, so there is no immediate cash transaction or open-market purchase/sale.

Key Details

• Transaction date: 2026-02-26 (Form 4 filed 2026-03-02).
• Amount: 3,190 restricted stock units. Price/total value: not applicable / not reported.
• Vesting/settlement: RSUs vest on the date of the 2027 Annual Meeting of Stockholders and are settled one-for-one in shares of common stock (Footnotes F1, F2).
• Shares owned after transaction: not provided in the supplied data.
• Filing timeliness: Form filed Mar 2, 2026 covering the Feb 26, 2026 grant; no late-filing flag indicated in the provided information.

Context
RSU awards are a form of equity compensation typically granted to directors and executives and do not represent an immediate market purchase or sale. They convert into ordinary shares only after vesting (here, at the 2027 annual meeting), so they are best viewed as compensation that may dilute outstanding shares upon settlement rather than a direct insider investment signal.